See also this year's filing and all EDGAR filings for this company.
PDF Report 0001411158_2016_Anacor_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001411158, Anacor Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 170,095,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,298,000 |
| 3 | remainder_Assets | 3,709,000 |
| 4 | LiabilitiesCurrent | 29,509,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 207,785,973 |
| 9 | ResearchAndDevelopmentExpense | 73,789,947 |
| 10 | remainder_Expenses | 47,987,043 |
| 11 | remainder_Revenues | 389,793,540 |
| 12 | remainder_NetIncome | -287,909 |
| 13 | remainder_ComprehensiveNetIncome | 180,069 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 176,102,000 |
| 1 | Liabilities | 29,509,000 |
| 2 | Expenses | 329,562,963 |
| 3 | Revenues | 389,793,540 |
| 4 | StockholdersEquity | 146,593,000 |
| 5 | NetIncome | 59,942,668 |
| 6 | ComprehensiveNetIncome | 60,032,702 |
| 7 | BaseVar | 462,717,740 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.69 |
| 9 | EconomicCapitalRatio | 4.17 |
Edgar->Model Mapping
Feature Distribution
Change over Time
